Synthon chooses Kuehne+Nagel to expand its distribution services in Chile

- The pharmaceutical company seeks efficiency and modernization in its logistics operations
- Applying environmentally friendly processes is an important part of the new agreement
- Capacity of 2,500 locations for finished product, raw materials and nutritional products

Specialized storage and distribution services for health care products is what Synthon, one of the leading transnational companies in the pharmaceutical products sector, officially launched in June, together with Kuehne+Nagel, a global company specialized in logistics. , whom they chose to strengthen and expand their business in Chile where they will distribute more than 400,000 units per year.

In Santiago, Kuehne+Nagel has a modern Distribution Center specialized in the Healthcare industry, located in Pudahuel. This center has the capacity to handle pharmaceutical, nutritional and cosmetic products, and is equipped with a Quality Control Laboratory and a Packaging Laboratory. In addition, it allows storage at a controlled temperature of 15 to 25°C thanks to a geothermal system that guarantees greater energy efficiency.

Synthon's inventory is expected to reach 2,500 pallet locations, allowing it to distribute more than 400,000 units per year to its main clients, such as the Supply Center of the National Health Services System (Cenabast), pharmaceutical chains and hospitals throughout from the country.

"At Kuehne+Nagel we are committed to life, ensuring a high level of quality with our global standard for the transport, handling and storage of medical products. We are very grateful for the trust that Synthon shows by choosing us as its strategic partner, which It also reinforces our position in the market and our commitment to innovation and excellence in our operations," commented Javier Ansó, National Manager of Contract Logistics at Kuehne+Nagel.

For its part, Synthon assures that “We specialize in the development, production and marketing of high-quality generic medicines globally. The partnership with Kuehne+Nagel strengthens our commitment to operational excellence through World Class processes in both companies. We are currently the only laboratory in Chile authorized by the European Union to export locally manufactured medicines, so this strategic alliance reinforces this commitment to patients in Chile and the world,” adds Claudio Sepúlveda Director Supply Chain Chile of Synthon.

The distribution center operates with renewable energy sources, such as solar and wind, ensuring the greatest efficiency in energy consumption. With this agreement, both companies seek to be prepared to increasingly better understand the needs of the pharmaceutical sector in Chile, offering cutting-edge logistics solutions that ensure the integrity and traceability of products at all stages of the value chain.

About Kuehne+Nagel
With around 81,000 employees at almost 1,300 sites in around 100 countries, the Kuehne+Nagel Group is one of the world's leading logistics providers. Headquartered in Switzerland, Kuehne+Nagel is listed on the Swiss blue-chip stock index, the SMI. The Group is a global leader in air and sea logistics and has a strong market position in land and contract logistics.

Kuehne+Nagel is the preferred logistics partner for 400,000 customers worldwide. Using its global network, logistics expertise and data-driven insights, the Group offers comprehensive supply chain solutions for global businesses and industries. As a member of the Science Based Target Initiative (SBTi), Kuehne+Nagel is committed to sustainable logistics by reducing its own environmental footprint and supporting its customers with low-carbon logistics solutions.

About Synthon
Founded in 1991, Synthon has been a leader in the development, manufacturing and commercialization of complex generics for over three decades. With a focus on innovation, science and intellectual property to drive differentiation, Synthon has become the leading B2B and D2M player in the generics industry. As a research leader, we combine our three strengths: Research & Development, Manufacturing and Marketing to make complex generic medicines available in all markets globally. Using the most advanced technologies, manufacturing processes and quality systems, Synthon has built an impressive portfolio of generic products across multiple therapeutic areas and dosage forms.